Show simple item record

dc.contributor.authorRusso, S
dc.contributor.authorWalker, JL
dc.contributor.authorCarlson, JW
dc.contributor.authorCarter, J
dc.contributor.authorWard, LC
dc.contributor.authorCovens, A
dc.contributor.authorTanner, EJ
dc.contributor.authorArmer, JM
dc.contributor.authorRidner, S
dc.contributor.authorHayes, S
dc.contributor.authorTaghian, AG
dc.contributor.authorBrunelle, C
dc.contributor.authorLopez-Acevedo, M
dc.contributor.authorDavidson, BA
dc.contributor.authoret al.
dc.date.accessioned2021-04-20T00:10:01Z
dc.date.available2021-04-20T00:10:01Z
dc.date.issued2021
dc.identifier.issn0090-8258en_US
dc.identifier.doi10.1016/j.ygyno.2020.10.026en_US
dc.identifier.urihttp://hdl.handle.net/10072/403359
dc.description.abstractPractice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.en_US
dc.description.peerreviewedYesen_US
dc.languageengen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofpagefrom625en_US
dc.relation.ispartofpageto632en_US
dc.relation.ispartofissue2en_US
dc.relation.ispartofjournalGynecologic Oncologyen_US
dc.relation.ispartofvolume160en_US
dc.subject.fieldofresearchOncology and Carcinogenesisen_US
dc.subject.fieldofresearchPaediatrics and Reproductive Medicineen_US
dc.subject.fieldofresearchcode1112en_US
dc.subject.fieldofresearchcode1114en_US
dc.subject.keywordsGynecologic cancersen_US
dc.subject.keywordsLymphedemaen_US
dc.subject.keywordsOncologic surgical treatmenten_US
dc.subject.keywordsPatient reported outcomesen_US
dc.subject.keywordsQuantitative measurementsen_US
dc.titleStandardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancersen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationRusso, S; Walker, JL; Carlson, JW; Carter, J; Ward, LC; Covens, A; Tanner, EJ; Armer, JM; Ridner, S; Hayes, S; Taghian, AG; Brunelle, C; Lopez-Acevedo, M; Davidson, BA; et al., Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers, Gynecologic Oncology, 2021, 160 (2), pp. 625-632en_US
dcterms.dateAccepted2020-10-20
dcterms.licensehttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.date.updated2021-03-22T23:55:16Z
dc.description.versionAccepted Manuscript (AM)en_US
gro.rights.copyright© 2021 Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.en_US
gro.hasfulltextFull Text
gro.griffith.authorHayes, Sandi C.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record